Home RTI-HS, FDA partner to study patients' preferences that contributed to approval of new obesity device
 

Keywords :   


RTI-HS, FDA partner to study patients' preferences that contributed to approval of new obesity device

2015-02-02 14:32:07| Industrial Machines - Topix.net

RTI Health Solutions , a business unit of RTI International, partnered with the U.S. Food and Drug Administration to conduct a study on patients' preferences which contributed to the Agency's regulatory decision to approve the Maestro Rechargeable System, a first-of-kind device to treat obesity. In addition to clinical study results, FDA considered the study results to quantify patients' preferences for benefits and acceptability of risks of various obesity devices.

Tags: study partner device approval

Category:Industrial Goods and Services

Latest from this category

All news

19.11POWTEX2024 The 25th International Powder Technology Exhibition Tokyo
Industrial Goods and Services »
27.11Washington Corner | November 2024
27.11
27.11MTG 4
27.1119
27.11
27.11Y-3
27.11
27.1125th PSA10
More »